immune system
N |
• mice do not exhibit any altered lung inflammation
|
• lung infiltrates are observed 6 hours after exposure to group B streptococcus (GBS) compared to in similarly treated wild-type mice that show infiltrate after 24 hours
• at 48 hours post-infection with GBS, inflammation persists and is more severe than in similarly treated wild-type mice
|
• lung infiltrates are observed 6 hours after exposure to group B streptococcus (GBS) compared to in similarly treated wild-type mice that show infiltrate after 24 hours
(J:110382)
• at 48 hours post-infection with GBS, inflammation persists and is more severe than in similarly treated wild-type mice
mice exhibit reduced bacterial clearance compared to wild-type mice
(J:110382)
• mice exhibit increased systemic infection with GBS compared to wild-type mice with increased splenic burden
(J:110382)
• GBS associated with alveolar macrophages is decreased compared to in wild-type mice
(J:110382)
• mice exhibit increased susceptibility to infection with Pneumocystis carinii compared to wild-type mice
(J:120552)
|
respiratory system
N |
• mice do not exhibit any altered lung structure, alveolar phospholipids pool size or composition, or lung inflammation
|
• lung infiltrates are observed 6 hours after exposure to group B streptococcus (GBS) compared to in similarly treated wild-type mice that show infiltrate after 24 hours
• at 48 hours post-infection with GBS, inflammation persists and is more severe than in similarly treated wild-type mice
|
• surfactant exhibits decreased minimum surface tension and increased sensitivity to plasma inactivation compared to wild-type surfactant
• mice exhibit fewer large aggregates of surfactant compared to in wild-type mice
• the number of large surfactant aggregates following exposure to NMU (N-nitroso-N-methylurea) is decreased compared to in similarly treated wild-type mice
|